Chemoinformaics analysis of Stigmasta-5,22-dien-3-ol
| Molecular Weight | 412.702 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
| Exact Molecular Weight | 412.371 | nRing | 4 |
| Solubility: LogS | -6.978 | nHRing | 0 |
| Solubility: LogP | 7.436 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 1 | BPOL | 48.1539 |
| QED | 0.457 |
| Synth | 4.571 |
| Natural Product Likeliness | 2.802 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.066 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.668 |
| MDCK | 0.00000752 |
| BBB | 0.691 |
| PPB | 0.986714 |
| VDSS | 2.408 |
| FU | 0.0157289 |
| CYP1A2-inh | 0.041 |
| CYP1A2-sub | 0.603 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.132 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.643 |
| CYP3a4-inh | 0.339 |
| CYP3a4-sub | 0.852 |
| CL | 15.958 |
| T12 | 0.014 |
| hERG | 0.012 |
| Ames | 0.029 |
| ROA | 0.054 |
| SkinSen | 0.025 |
| Carcinogencity | 0.054 |
| EI | 0.01 |
| Respiratory | 0.19 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.678113 |